From: Leukocyte count and incidence of subarachnoid haemorrhage: a prospective cohort study
Q1 | Q2 | Q3 | Q4 | p trend | All | |
---|---|---|---|---|---|---|
n | 5110 | 4864 | 4794 | 5026 | 19,794 | |
Leukocytes, 109 cells/L | 3.93 ± 0.5 | 5.17 ± 0.3 | 6.33 ± 0.4 | 8.74 ± 1.6 | 6.04 ± 2.01 | |
Leukocytes, 109 cells/L, range | 2.0-4.6 | 4.6-5.7 | 5.6-7.0 | 7.1-19.2 | 2.0-19.2 | |
Women, % | 13.4 | 13.1 | 15.1 | 13.2 | 13.7 | |
Age, years | 43.6 ± 6.1 | 43.8 ± 6.0 | 43.7 ± 6.1 | 43.9 ± 5.9 | 0.055 | 43.7 ± 6.0 |
Systolic blood pressure, mmHg | 126 ± 14 | 127 ± 15 | 127 ± 16 | 127 ± 16 | 0.028 | 126 ± 15 |
Smoking status, % | ||||||
Never smokers | 50.2 | 38.2 | 27.5 | 13.2 | < 0.001 | 32.3 |
Former smokers | 24.6 | 22.4 | 16.4 | 8.4 | < 0.001 | 18.0 |
Current smokers | 25.2 | 39.4 | 56.1 | 78.4 | < 0.001 | 49.7 |
High alcohol consumption, % | 12.1 | 13.3 | 14.5 | 17.6 | < 0.001 | 14.4 |
Antihypertensive medication, % | 3.4 | 3.6 | 4.1 | 4.0 | 0.057 | 3.8 |
Body mass index, kg/m2 | 24.2 ± 3.1 | 24.6 ± 3.4 | 24.7 ± 3.6 | 24.4 ± 3.5 | 0.002 | 24.5 ± 3.4 |
Cholesterol, mmol/L | 5.51 ± 1.0 | 5.58 ± 1.0 | 5.62 ± 1.0 | 5.76 ± 1.1 | < 0.001 | 5.61 ± 1.1 |
Diabetes, % | 2.1 | 2.2 | 2.6 | 2.9 | 0.005 | 2.5 |
Physical inactivity, % | 50.9 | 54.8 | 56.7 | 58.9 | < 0.001 | 55.3 |
History of MI or AP, % | 1.8 | 1.5 | 2.0 | 2.1 | 0.093 | 1.8 |
FEV1, % of predicted | 97.5 ± 17.6 | 95.6 ± 17.4 | 93.4 ± 17.4 | 91.1 ± 17.5 | < 0.001 | 94.4 ± 17.7 |